
John Kwon
Examiner (ID: 226, Phone: (571)272-4846 , Office: P/3747 )
| Most Active Art Unit | 3747 |
| Art Unit(s) | 2403, 2605, 3747, 2402, 3745, 3404, 3401, 3754, 3622 |
| Total Applications | 4781 |
| Issued Applications | 4291 |
| Pending Applications | 92 |
| Abandoned Applications | 420 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7518935
[patent_doc_number] => 07973036
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-07-05
[patent_title] => '2-methyl-5-imino-benzo[D][1 ,3]oxazin[5-B]pyrazole compound, preparation and use thereof'
[patent_app_type] => utility
[patent_app_number] => 13/054674
[patent_app_country] => US
[patent_app_date] => 2009-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 9
[patent_no_of_words] => 4366
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/973/07973036.pdf
[firstpage_image] =>[orig_patent_app_number] => 13054674
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/054674 | 2-methyl-5-imino-benzo[D][1 ,3]oxazin[5-B]pyrazole compound, preparation and use thereof | Mar 19, 2009 | Issued |
Array
(
[id] => 5404733
[patent_doc_number] => 20090240048
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-24
[patent_title] => 'Alpha-crystalline form of substituted selenoxanthenes and the method of its preparation'
[patent_app_type] => utility
[patent_app_number] => 12/406461
[patent_app_country] => US
[patent_app_date] => 2009-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 1496
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0240/20090240048.pdf
[firstpage_image] =>[orig_patent_app_number] => 12406461
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/406461 | Alpha-crystalline form of substituted selenoxanthenes and the method of its preparation | Mar 17, 2009 | Abandoned |
Array
(
[id] => 6136027
[patent_doc_number] => 20110009263
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-13
[patent_title] => 'SELECTED SALTS OF 3-(5,6-DIHYDRO-1,4,2-DIOXAZIN-3-YL)-N-[(4,6-DIMETHOXYPYRIMIDIN-2-YL)CARBAMOYL]PYRIDINE-2-SULFONAMIDE, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF AS HERBICIDES AND PLANT GROWTH REGULATORS'
[patent_app_type] => utility
[patent_app_number] => 12/920547
[patent_app_country] => US
[patent_app_date] => 2009-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15739
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20110009263.pdf
[firstpage_image] =>[orig_patent_app_number] => 12920547
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/920547 | SELECTED SALTS OF 3-(5,6-DIHYDRO-1,4,2-DIOXAZIN-3-YL)-N-[(4,6-DIMETHOXYPYRIMIDIN-2-YL)CARBAMOYL]PYRIDINE-2-SULFONAMIDE, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF AS HERBICIDES AND PLANT GROWTH REGULATORS | Mar 12, 2009 | Abandoned |
Array
(
[id] => 6149855
[patent_doc_number] => 20110021450
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-27
[patent_title] => 'MEDICINAL COMPOSITION CONTAINING BENZO[A]PHENOXAZINE COMPOUND AS THE ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF PROTOZOAL DISEASE'
[patent_app_type] => utility
[patent_app_number] => 12/921569
[patent_app_country] => US
[patent_app_date] => 2009-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12544
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20110021450.pdf
[firstpage_image] =>[orig_patent_app_number] => 12921569
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/921569 | Medicinal composition containing benzo[a]phenoxazine compound as the active ingredient for prevention or treatment of protozoal disease | Mar 10, 2009 | Issued |
Array
(
[id] => 102316
[patent_doc_number] => 07727983
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-01
[patent_title] => 'Oxadiazoanthracene compounds for the treatment of diabetes'
[patent_app_type] => utility
[patent_app_number] => 12/399504
[patent_app_country] => US
[patent_app_date] => 2009-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47095
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/727/07727983.pdf
[firstpage_image] =>[orig_patent_app_number] => 12399504
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/399504 | Oxadiazoanthracene compounds for the treatment of diabetes | Mar 5, 2009 | Issued |
Array
(
[id] => 5539760
[patent_doc_number] => 20090221565
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-03
[patent_title] => 'NOVEL 7-SUBSTITUTED 3-CARBOXY-OXADIAZINO-QUINOLONE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS ANTI-BACTERIALS'
[patent_app_type] => utility
[patent_app_number] => 12/394918
[patent_app_country] => US
[patent_app_date] => 2009-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30522
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20090221565.pdf
[firstpage_image] =>[orig_patent_app_number] => 12394918
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/394918 | 7-substituted 3-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials | Feb 26, 2009 | Issued |
Array
(
[id] => 5485792
[patent_doc_number] => 20090275557
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-05
[patent_title] => 'Novel Composition for Treatment of Diseases Related to Activated Lymphocytes'
[patent_app_type] => utility
[patent_app_number] => 12/393888
[patent_app_country] => US
[patent_app_date] => 2009-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 20345
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20090275557.pdf
[firstpage_image] =>[orig_patent_app_number] => 12393888
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/393888 | Novel Composition for Treatment of Diseases Related to Activated Lymphocytes | Feb 25, 2009 | Abandoned |
Array
(
[id] => 5515456
[patent_doc_number] => 20090215763
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-27
[patent_title] => 'SUBSTITUTED BENZOXAZINONES'
[patent_app_type] => utility
[patent_app_number] => 12/392992
[patent_app_country] => US
[patent_app_date] => 2009-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 14142
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20090215763.pdf
[firstpage_image] =>[orig_patent_app_number] => 12392992
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/392992 | SUBSTITUTED BENZOXAZINONES | Feb 24, 2009 | Abandoned |
Array
(
[id] => 6149935
[patent_doc_number] => 20110021530
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-27
[patent_title] => 'PYRIDAZINE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS IN THE TREATMENT OF SKIN DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 12/919232
[patent_app_country] => US
[patent_app_date] => 2009-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 67092
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20110021530.pdf
[firstpage_image] =>[orig_patent_app_number] => 12919232
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/919232 | PYRIDAZINE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS IN THE TREATMENT OF SKIN DISORDERS | Feb 18, 2009 | Abandoned |
Array
(
[id] => 8701569
[patent_doc_number] => 08394791
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-03-12
[patent_title] => 'Crystalline, enantiomerically pure salt form of a beta-agonist, and the use thereof as a drug'
[patent_app_type] => utility
[patent_app_number] => 12/918374
[patent_app_country] => US
[patent_app_date] => 2009-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8455
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12918374
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/918374 | Crystalline, enantiomerically pure salt form of a beta-agonist, and the use thereof as a drug | Feb 16, 2009 | Issued |
Array
(
[id] => 173886
[patent_doc_number] => 07659265
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-02-09
[patent_title] => 'Thioamide derivatives as progesterone receptor modulators'
[patent_app_type] => utility
[patent_app_number] => 12/369789
[patent_app_country] => US
[patent_app_date] => 2009-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7694
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/659/07659265.pdf
[firstpage_image] =>[orig_patent_app_number] => 12369789
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/369789 | Thioamide derivatives as progesterone receptor modulators | Feb 11, 2009 | Issued |
Array
(
[id] => 6351965
[patent_doc_number] => 20100331322
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-30
[patent_title] => 'SUBSTITUTED PIPERIDINES AS RENIN INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/865932
[patent_app_country] => US
[patent_app_date] => 2009-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15606
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0331/20100331322.pdf
[firstpage_image] =>[orig_patent_app_number] => 12865932
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/865932 | Substituted piperidines as renin inhibitors | Feb 5, 2009 | Issued |
Array
(
[id] => 4644463
[patent_doc_number] => 08022068
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-09-20
[patent_title] => 'Substituted piperidines as renin inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/865930
[patent_app_country] => US
[patent_app_date] => 2009-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14830
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/022/08022068.pdf
[firstpage_image] =>[orig_patent_app_number] => 12865930
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/865930 | Substituted piperidines as renin inhibitors | Feb 5, 2009 | Issued |
Array
(
[id] => 6055930
[patent_doc_number] => 20110112290
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-12
[patent_title] => ' PROCESS FOR THE PREPARATION OF QUETIAPINE'
[patent_app_type] => utility
[patent_app_number] => 12/811536
[patent_app_country] => US
[patent_app_date] => 2009-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3283
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20110112290.pdf
[firstpage_image] =>[orig_patent_app_number] => 12811536
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/811536 | Process for the preparation of quetiapine | Jan 29, 2009 | Issued |
Array
(
[id] => 6168403
[patent_doc_number] => 20110196151
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-11
[patent_title] => 'PROCESS FOR THE PREPARATION OF EFAVIRENZ'
[patent_app_type] => utility
[patent_app_number] => 13/060839
[patent_app_country] => US
[patent_app_date] => 2009-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1870
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20110196151.pdf
[firstpage_image] =>[orig_patent_app_number] => 13060839
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/060839 | Process for the preparation of efavirenz | Jan 29, 2009 | Issued |
Array
(
[id] => 5527801
[patent_doc_number] => 20090197878
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-06
[patent_title] => 'SUBSTITUTED BENZO[d][1,3]OXAZIN-2(4H)-ONES AND RELATED DERIVATIVES AND THEIR USES FOR MODULATING THE PROGESTERONE RECEPTOR'
[patent_app_type] => utility
[patent_app_number] => 12/361764
[patent_app_country] => US
[patent_app_date] => 2009-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19309
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20090197878.pdf
[firstpage_image] =>[orig_patent_app_number] => 12361764
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/361764 | SUBSTITUTED BENZO[d][1,3]OXAZIN-2(4H)-ONES AND RELATED DERIVATIVES AND THEIR USES FOR MODULATING THE PROGESTERONE RECEPTOR | Jan 28, 2009 | Abandoned |
Array
(
[id] => 92286
[patent_doc_number] => 07732449
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-08
[patent_title] => 'Inhibitors of cathepsin S'
[patent_app_type] => utility
[patent_app_number] => 12/361287
[patent_app_country] => US
[patent_app_date] => 2009-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 34679
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/732/07732449.pdf
[firstpage_image] =>[orig_patent_app_number] => 12361287
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/361287 | Inhibitors of cathepsin S | Jan 27, 2009 | Issued |
Array
(
[id] => 5576007
[patent_doc_number] => 20090143369
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-04
[patent_title] => 'METHODS OF USING SUBSTITUTED MORPHOLINE AND THIOMORPHOLINE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 12/361404
[patent_app_country] => US
[patent_app_date] => 2009-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26499
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20090143369.pdf
[firstpage_image] =>[orig_patent_app_number] => 12361404
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/361404 | METHODS OF USING SUBSTITUTED MORPHOLINE AND THIOMORPHOLINE DERIVATIVES | Jan 27, 2009 | Abandoned |
Array
(
[id] => 202752
[patent_doc_number] => 07632835
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-12-15
[patent_title] => 'Substituted morpholine and thiomorpholine derivatives'
[patent_app_type] => utility
[patent_app_number] => 12/361509
[patent_app_country] => US
[patent_app_date] => 2009-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26596
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/632/07632835.pdf
[firstpage_image] =>[orig_patent_app_number] => 12361509
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/361509 | Substituted morpholine and thiomorpholine derivatives | Jan 27, 2009 | Issued |
Array
(
[id] => 102342
[patent_doc_number] => 07727999
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-01
[patent_title] => 'Spiroazacyclic compounds as monoamine receptor modulators'
[patent_app_type] => utility
[patent_app_number] => 12/360478
[patent_app_country] => US
[patent_app_date] => 2009-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 22779
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/727/07727999.pdf
[firstpage_image] =>[orig_patent_app_number] => 12360478
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/360478 | Spiroazacyclic compounds as monoamine receptor modulators | Jan 26, 2009 | Issued |